{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:18:43Z","timestamp":1783577923819,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["31372401"],"award-info":[{"award-number":["31372401"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["31372411"],"award-info":[{"award-number":["31372411"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key project of Shaanxi province Science and Technology Innovation Team","award":["2013KCT-28"],"award-info":[{"award-number":["2013KCT-28"]}]},{"name":"Key project of Shaanxi province Science and Technology Innovation Team","award":["2016KTCL02-13"],"award-info":[{"award-number":["2016KTCL02-13"]}]},{"name":"Key project of Shaanxi province Science and Technology Innovation Team","award":["2452017023"],"award-info":[{"award-number":["2452017023"]}]},{"name":"Science and Technology Innovation project in Shaanxi province"},{"name":"Young Talent Development Program of Northwest A&F University"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.vaccine.2017.07.031","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T19:46:20Z","timestamp":1501098380000},"page":"4722-4729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Immunogenicity of adenovirus vaccines expressing the PCV2 capsid protein in pigs"],"prefix":"10.1016","volume":"35","author":[{"given":"Delong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juejun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2017.07.031_b0005","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/104063870701900601","article-title":"Porcine circovirus type 2-associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies","volume":"19","author":"Opriessnig","year":"2007","journal-title":"J Vet Diagn Invest"},{"issue":"15","key":"10.1016\/j.vaccine.2017.07.031_b0010","doi-asserted-by":"crossref","first-page":"7856","DOI":"10.1128\/JVI.00737-11","article-title":"The 2.3-angstrom structure of porcine circovirus 2","volume":"85","author":"Khayat","year":"2011","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2017.07.031_b0015","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/JVI.80.7.3487-3494.2006","article-title":"Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate B glycosaminoglycans as receptorsfor its attachment to host cells","volume":"80","author":"Misinzo","year":"2006","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.07.031_b0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.molimm.2008.10.028","article-title":"Fine mapping of antigenic epitopes on capsid proteins of porcine circovirus, and antigenic phenotype of porcine circovirus type 2","volume":"46","author":"Shang","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2017.07.031_b0025","unstructured":"Pogranichniy R, Yoonl KJ, Yaeger M. Possible prevention of PMWS using inactivated PCV2 vaccine in CDCD pigs. In: Proceedings of the 18th IPVS Congress 2004; vol. 1. p. 55."},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2017.07.031_b0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.vetmic.2005.06.001","article-title":"Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2","volume":"109","author":"Ju","year":"2005","journal-title":"Vet Microbiol"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2017.07.031_b0035","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.vaccine.2004.01.032","article-title":"Immunisation against PCV2 structural protein by DNA vaccination of mice","volume":"22","author":"Kamstrup","year":"2004","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2017.07.031_b0040","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1128\/JVI.78.12.6297-6303.2004","article-title":"A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs","volume":"78","author":"Fenaux","year":"2004","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2017.07.031_b0045","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1007\/s00253-012-4540-z","article-title":"High-level expression and immunogenicity of a porcine circovirus type 2 capsid protein through codon optimization in Pichia pastoris","volume":"97","author":"Tu","year":"2013","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2017.07.031_b0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virusres.2011.09.041","article-title":"Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2)","volume":"164","author":"Beach","year":"2012","journal-title":"Virus Res"},{"issue":"5","key":"10.1016\/j.vaccine.2017.07.031_b0055","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0958-1669(99)00007-5","article-title":"Adenovirus vectors for gene delivery","volume":"10","author":"Benihoud","year":"1999","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.07.031_b0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12033-007-0021-5","article-title":"Adenoviral vectors for gene therapy","volume":"36","author":"Douglas","year":"2007","journal-title":"Mol Biotechnol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.07.031_b0065","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1038\/sj.gt.3302618","article-title":"Use of adenoviral vectors as veterinary vaccines","volume":"12","author":"Ferreira","year":"2005","journal-title":"Gene Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2017.07.031_b0070","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0958-1669(97)80033-X","article-title":"Adenoviral vectors for gene transfer","volume":"8","author":"Kovesdi","year":"1997","journal-title":"Curr Opin Biotechnol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.07.031_b0075","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1128\/JVI.69.4.2004-2015.1995","article-title":"Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses","volume":"69","author":"Yang","year":"1995","journal-title":"J Virol"},{"issue":"16","key":"10.1016\/j.vaccine.2017.07.031_b0080","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1016\/j.vaccine.2005.12.068","article-title":"Construction and immunogenicity of recombinant adenovirus expressing the capsid protein of porcine circovirus 2 (PCV2) in mice","volume":"24","author":"Wang","year":"2006","journal-title":"Vaccine"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2017.07.031_b0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vetmic.2006.11.027","article-title":"Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2","volume":"121","author":"Wang","year":"2007","journal-title":"Vet. Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.07.031_b0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4149\/av_2016_03_271","article-title":"Modified recombinant adenoviruses increase porcine circovirus 2 capsid protein expression and induce enhanced immune responses in mice","volume":"60","author":"Li","year":"2016","journal-title":"Acta Virologica"},{"issue":"3","key":"10.1016\/j.vaccine.2017.07.031_b0095","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/vim.2015.0109","article-title":"CD40 ligand and GMCSF co-expression enhances the immune responses and protective efficacy of PCV2 adenovirus vaccine","volume":"29","author":"Li","year":"2016","journal-title":"Viral Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.07.031_b0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/vim.2016.0086","article-title":"Immunogenicity evaluation of modified adenovirus vaccines expressing porcine circovirus type 2 capsid protein in pigs","volume":"30","author":"Li","year":"2017","journal-title":"Viral Immunol."},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2017.07.031_b0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.vetimm.2005.09.016","article-title":"Immunopathological effects of porcine circovirus type 2 (PCV2) on swine alveolar macrophages by in vitro inoculation","volume":"110","author":"Chang","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.07.031_b0110","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/JVI.54.3.651-660.1985","article-title":"Nucleotide and amino acid sequence coding for polypeptides of foot-andmouth disease virus type A12","volume":"54","author":"Robertson","year":"1985","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2017.07.031_b0115","first-page":"27493","article-title":"A simple method of estimating fifty percent endpoint","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"issue":"14","key":"10.1016\/j.vaccine.2017.07.031_b0120","doi-asserted-by":"crossref","first-page":"17492","DOI":"10.18632\/oncotarget.7362","article-title":"Porcine circovirus type 2 activates PI3K\/Akt and p38 MAPK pathways to promote interleukin-10 production in macrophages via Cap interaction of gC1qR","volume":"7","author":"Du","year":"2016","journal-title":"Oncotarget"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17309398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17309398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T12:39:04Z","timestamp":1602592744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17309398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":24,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0264410X17309398"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity of adenovirus vaccines expressing the PCV2 capsid protein in pigs","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}